Washington Examiner
Sign in
SUBSCRIBE
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Epipen

Tag: Epipen

Cleveland Police Sgt. Ray O’Connor thanked Tomika Johnson and her family for their efforts in saving his life after he was stung by two bees. News

SEE IT: Police officer thanks woman who saved him with EpiPen after bee stings

Heather Hamilton · August 25, 2022 1:34 pm
In this Sept. 21, 2016, file photo, EpiPens brought by Mylan CEO Heather Bresch are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Healthcare

New generic EpiPen not any cheaper

Robert King · November 27, 2018 4:27 pm
A pharmacist holds a package of EpiPen epinephrine auto-injectors. Healthcare

FDA approves first generic competitor for EpiPen

Robert King · August 16, 2018 7:19 pm
Mylan has agreed to repay $465 million to the federal government for overbilling for its lifesaving EpiPen allergy antidote. The settlement comes at the end of an investigation that found Mylan avoided paying state Medicaid programs higher rebates for the EpiPen by improperly naming it as a generic medication. (AP Photo/Pablo Martinez Monsivais, File) Healthcare

Mylan agrees to pay back government $465 million for EpiPen overbilling

Kimberly Leonard · August 17, 2017 8:01 pm
Representatives of drugmaker Mylan, which produces the allergy drug EpiPen, wants to meet with Sen. Chuck Grassley to discuss a subpoena threat over documents pertaining to Medicaid's rebate program. (AP Photo/Rich Pedroncelli, File) Healthcare

EpiPen maker seeks meeting with Chuck Grassley over subpoena threat, report says

Robert King · June 2, 2017 2:31 pm
The HHS inspector general's office found that the government overpaid about $1.27 billion for the allergy antidote under the Medicaid rebate program. (AP Photo/Rich Pedroncelli, File) Healthcare

Grassley: Mylan fleeced taxpayers $1.27 billion for EpiPen

Robert King · May 31, 2017 7:38 pm
"Mylan engaged in illegal conduct to squelch this nascent competition, harming both Sanofi and U.S. consumers," Sanofi wrote in the complaint. (AP Photo/Rich Pedroncelli, File) Healthcare

Sanofi sues Mylan for illegally trying to ‘squelch’ EpiPen competition

Kimberly Leonard · April 24, 2017 5:21 pm
Pharmaceuticals company Mylan, which distributes the Epipen, a device for severe allergic reactions, is back in the news. (AP Photo/Rich Pedroncelli, File) Healthcare

Mylan issues nationwide recall for Epipens with defective injectors

Mairead McArdle · April 1, 2017 2:57 am
The new version of the EpiPen will cost half as much, as the company responds to public outrage. (AP Photo/Pablo Martinez Monsivais, File) Healthcare

Lawmakers say Mylan stonewalling them

Robert King · February 3, 2017 10:38 pm
Mylan CEO Heather Bresch reflected Wednesday on what she learned from months of public outrage over her company's dramatic price increase for the EpiPen allergy shot. (AP Photo/Pablo Martinez Monsivais) Healthcare

What Mylan’s CEO learned from the EpiPen outrage

Paige Winfield Cunningham · January 11, 2017 10:26 pm
EpiPen maker says ensuring annual increases are below 10 percent, as some have suggested, isn't the answer. (AP Photo/Rich Pedroncelli) Healthcare

Mylan CEO stresses market-based solution to drug pricing

Paige Winfield Cunningham · January 11, 2017 6:32 pm
The Obama administration found that drug spending on Medicare Part D, the program's prescription drug program, was $121 billion in 2014, a 17 percent increase from 2013. (AP Photo) Healthcare

Lawmakers demand to know if drug maker lied to them

Robert King · December 16, 2016 9:31 pm
Advertisement
  • 1
  • 2
  • 3
  • …
  • 5
  • ›Next page
Page 1 of 5
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement